Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pazobrite 200mg Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Pazopanib (200mg)

Overview Pazobrite 200mg Tablet

For kidney cancer and soft tissue sarcoma, the 200mg Pazobrite tablet, a protein kinase inhibitor, is prescribed. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician based on your condition and may adjust over time; adhere strictly to their instructions. Incorrect usage or overdose can have severe consequences. Therapeutic effects might not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include elevated blood pressure and diarrhea; regular blood pressure monitoring may be advised. Hydration is crucial for diarrhea management; consult your doctor if it persists. Reduced blood cell counts, increasing infection risk, may occur; report fever, flu-like symptoms, or breathlessness immediately. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, including those for infections, to your physician. Numerous drug interactions are possible; ensure your healthcare provider has a complete medication list. Pregnancy and breastfeeding are contraindicated; reliable contraception for both partners is essential during treatment.

Primary Ingredients of Pazobrite 200mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Pazobrite 200mg Tablet

Renal cell carcinoma and soft tissue sarcoma

Major Benefits of Pazobrite 200mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 200mg Pazobrite tablet whole; avoid chewing, crushing, or fracturing it. Consume on an empty stomach.

Common Side effects of Pazobrite 200mg Tablet:

  • Headache
  • Nausea
  • Vomiting
  • Musculoskeletal (bone, muscle or joint) pain
  • Fatigue
  • Change in color of hair
  • Diarrhea
  • High blood pressure
  • Decreased appetite
  • Weight loss
  • Taste change
  • Abnormal skin pigmentation
  • Hair discoloration
  • Tumor pain
  • Breathlessness

How to use Pazobrite 200mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 200mg Pazobrite tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Pazobrite 200mg Tablet works:

Pazobrite 200mg tablets are an anticancer drug that targets tyrosine kinase enzyme receptors. By binding to these receptors, it blocks their activity, thus hindering the uncontrolled multiplication of cancer cells. Furthermore, it suppresses the development of new blood vessels that nourish the tumor, effectively combating cancer growth.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction between alcohol and Pazobrite 200mg Tablet is currently undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Pazobrite 200mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and the use of Pazobrite 200mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking a 200mg Pazobrite tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney impairment can safely take Pazobrite 200mg tablets without requiring any alteration to the prescribed dosage.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Pazobrite 200mg tablets, as dose modification may be necessary. Consult a physician before use. Pazobrite 200mg tablets are contraindicated for patients exhibiting moderate to severe hepatic dysfunction.

What if you forget to take Pazobrite 200mg Tablet :

NA

Facts to Know About Pazobrite 200mg Tablet

LabelValue
Chemical Category Diarylalkanamines
Developing Habits No.
Treatment Category Cancer Medications
Action Category TKIs (Tyrosine Kinase Inhibitors)

FAQs on Pazobrite 200mg Tablet

Pazobrite 200mg tablets are not a standard chemotherapy drug; they're a protein kinase inhibitor. This medication functions by blocking the activity of proteins crucial to cancer cell growth and spread.
Take one Pazobrite 200mg tablet orally once daily, or as your doctor instructs. Swallow whole with water; do not crush or break the tablet, as this alters absorption and may increase side effects.
Take Pazobrite 200mg tablets on an empty stomach, at least one hour before or two hours after eating. Taking it with food may necessitate a higher dose, potentially increasing side effects.
Treatment duration with Pazobrite 200mg Tablet is individualized. Your doctor will determine the appropriate length of treatment based on your response and tolerance. Never discontinue use without consulting your doctor. Continue taking it as long as it remains beneficial and well-tolerated.
Grapefruit and grapefruit juice should be avoided while taking Pazobrite 200mg tablets, as they can interfere with the medication's effectiveness. Consult your doctor regarding other potential dietary restrictions.
Treatment duration with Pazobrite 200mg Tablet is individualized. Your doctor will determine the appropriate length of treatment based on your response and tolerance. Discontinue use only as directed by your physician.
Pazobrite 200mg Tablets can cause serious, even life-threatening, liver damage. Report any history of liver disease to your doctor. Immediately contact your doctor if you experience symptoms like jaundice (yellowing skin or eyes), dark urine, fatigue, nausea, vomiting, appetite loss, upper right abdominal pain, or unusual bleeding/bruising. Pre-treatment lab tests may be required, followed by tests at weeks 3, 5, 7, 9, and months 3 and 4. Further testing may be needed; regular monitoring will continue after 4 months.
Pazobrite 200mg Tablet
4,502
MRP 5,211
13% off